Turn Therapeutics

Company snapshot

Turn Therapeutics® is a a leader in inflammatory and infectious disease research. Our core mission is to leverage our expertise in drug delivery to create safe, effective, affordable products for high need indications.

• 6 active pipeline program(s) linked via ClinicalTrials.gov.
• 40 US patent(s) indexed to this assignee profile.
• 6 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Turn Therapeutics. Not investment advice.

• Peer + 0 momentum

  Bristol Myers Squibb

  TA overlap score 28

• Peer + 0 momentum

  Eikon Therapeutics

  TA overlap score 23

• Peer + 0 momentum

  Pyxis Oncology

  TA overlap score 21.6

Recent activity

Latest pipeline, patent, and corporate events for Turn Therapeutics.

1. Jun 8, 2026 Clinical update

   TPX-0005-07 — Phase 2

2. Jun 8, 2026 Clinical update

   CA177-1036 — Phase 1

3. Jun 5, 2026 Clinical update

   GX-03 — Phase 2

4. May 26, 2026 Clinical update

   Repotrectinib (TPX-0005) — Phase 2

5. May 23, 2026 Clinical update

   MiLES — Phase 3

View all clinical trial activity →

• What is Turn Therapeutics?

  Turn Therapeutics (Nasdaq: is a pharma organization headquartered in Westlake Village, USA. It trades on NYSE under ticker TTRX. Primary therapeutic focus areas include Advanced solid tumors, Advanced Solid Tumors, Covid19, Eczema Atopic Dermatitis, Cancer. NovaPharmaNews links 6

• Is Turn Therapeutics publicly traded?

  Yes. Turn Therapeutics is listed with ticker TTRX on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Turn Therapeutics develop or market?

  We link 3 drug profile(s) where Turn Therapeutics is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/turn-therapeutics#company-drugs.

• What are the latest developments for Turn Therapeutics?

  In the last 12 months our linked public records show 6 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Turn Therapeutics focus on?

  Turn Therapeutics focuses on Advanced solid tumors, Advanced Solid Tumors, Covid19 based on our analysis of their pipeline programs and drug development activities.